Transcept Pharmaceuticals, (TSPT) Posts Wider than Expected Q1 Loss of 37c/Share

Transcept Pharmaceuticals, Inc. (NASDAQ: TSPT) reported Q1 EPS of ($0.37), $0.17 better than the analyst estimate of ($0.54).

For earnings history and earnings-related data on Transcept Pharmaceuticals, Inc. (TSPT) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• CAE, Inc. (CAE) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY27 EPS Guidance
• Stantec (STN) Tops Q2 EPS by 47c